RGB-02

pegfilgrastim · Gedeon Richter Plc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RGB-02, covering 2017-11-22 to 2017-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta [Phase 1]